United Therapeutics (UTHR) Amortizatization of Intangibles (2009 - 2016)
United Therapeutics' (UTHR) quarterly Amortizatization of Intangibles came in at -$100000.0 in Q2 2016, up 75.0% year-on-year from -$57142.9 in Q3 2015, and up 50.0% quarter-over-quarter from -$200000.0 in Q1 2016.
United Therapeutics (UTHR) Amortizatization of Intangibles (2009 - 2016) Analysis & Trends
United Therapeutics has disclosed Amortizatization of Intangibles across 8 years of filings, most recently posting -$100000.0 for Q2 2016.
- Amortizatization of Intangibles for Q2 2016 came in at -$100000.0, up 75.0% year-over-year; the trailing twelve-month figure through Jun 2016 was -$1.0 million (up 71.67% YoY), and the FY2015 annual result was -$2.1 million, up 59.24% from the prior year.
- Amortizatization of Intangibles came in at -$100000.0 for Q2 2016 at United Therapeutics, up from -$200000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of -$100000.0 in Q2 2016 to a low of -$1.6 million in Q1 2014.
- The 5-year median for Amortizatization of Intangibles is -$1.0 million (2013), against an average of -$931555.6.
- Across the five-year window, Amortizatization of Intangibles tumbled 59.44% in 2014 and soared 80.0% in 2016, its largest moves.
- United Therapeutics' Amortizatization of Intangibles stood at -$1.3 million in 2012, then declined by 10.3% to -$1.4 million in 2013, then increased by 27.8% to -$1.0 million in 2014, then jumped by 74.32% to -$266000.0 in 2015, then soared by 62.41% to -$100000.0 in 2016.
- The last three Amortizatization of Intangibles figures came in at -$100000.0 (Q2 2016), -$200000.0 (Q1 2016), and -$266000.0 (Q4 2015), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | -100,000.00 |
| Jun 30, 2016 | -100,000.00 |
| Mar 31, 2016 | -200,000.00 |
| Mar 31, 2016 | -200,000.00 |
| Dec 31, 2015 | -266,000.00 |
| Dec 31, 2015 | -266,000.00 |
| Sep 30, 2015 | -466,000.00 |
| Sep 30, 2015 | -466,000.00 |
| Jun 30, 2015 | -400,000.00 |
| Jun 30, 2015 | -400,000.00 |
| Mar 31, 2015 | -1.00 Mn |
| Mar 31, 2015 | -1.00 Mn |
| Dec 31, 2014 | -1.04 Mn |
| Dec 31, 2014 | -1.04 Mn |
| Sep 30, 2014 | -1.21 Mn |
| Sep 30, 2014 | -1.21 Mn |
| Jun 30, 2014 | -1.38 Mn |
| Jun 30, 2014 | -1.38 Mn |
| Mar 31, 2014 | -1.60 Mn |
| Mar 31, 2014 | -1.60 Mn |